XM does not provide services to residents of the United States of America.

Cboe files for SEC approval to list Solana ETFs, starts clock for required decision



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CORRECTED-(OFFICIAL)-Cboe files for SEC approval to list Solana ETFs, starts clock for required decision</title></head><body>

In paragraph 6, Cboe corrects quote to say "one of the most actively traded" instead of "the third most actively traded"

By Suzanne McGee

July 8 (Reuters) -Exchange operator Cboe Global Markets CBOE.Z filed a request with the U.S. Securities and Exchange Commission on Monday seeking to list exchange-traded funds (ETFs) tied to cryptocurrency Solana, requiring the agency to make a decision by March.

Under SEC rules, the agency has 240 calendar days to decide whether to approve or deny Cboe's "19b-4" application to list the products from VanEck and digital asset manager 21Shares. They are the first proposed ETF products tied to the price of Solana, the fifth largest cryptocurrency, according to CoinGecko.

VanEck and 21Shares in June applied with the SEC to launch the new products. The SEC must also approve those "S-1" filings before the products can begin trading, but the agency's rules do set a deadline for those investor disclosure filings.

If approved, the products would mark a third wave of spot cryptocurrency ETFs, after the SEC in January approved ETFs tied to the price of bitcoin, in a watershed for the industry. Such products require a two-stage approval process.

"We are now addressing the increasing investor interest in Solana – one of themost actively traded cryptocurrency after Bitcoin and Ether," said Rob Marrocco, global head of ETP Listings at Cboe.

VanEck, 21Shares and other issuers are also waiting on the final green light from the SEC to launch ETFs tied to the spot price of the second-largest cryptocurrency, ethereum.

That go-ahead is likely to come within the next week, saidtwo people familiar with the process. Regulators have already approved the exchanges' application to list and trade those new products.

The price of Solana ishovering around $137.83, down from last month's peak of nearly $150 when the two ETF filings were first submitted, CoinGecko data showed.



Reporting by Suzanne McGee, Editing by Michelle Price and Richard Chang

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.